US Archives - Page 161 of 243 - European Medical Journal

Immunocompromised Patients with Meningitis/Encephalitis: CSF Profile Characterization

There are widely accepted ranges of typical cerebrospinal fluid (CSF) values used to guide diagnosis and treatment of suspected infectious…

What Is Next in Myasthenia Gravis? Insights on Ocular and MuSK Forms from AAN 2025

THE 2025 American Academy of Neurology (AAN) Annual Meeting saw experts in the field travel to San Diego, California, for the field’s…

Cocaine-Induced Leukoencephalopathy: A Case Report

Cocaine-induced leukoencephalopathy is a rare neurological condition usually associated with substances used to adulterate cocaine…

Neurological Complications of Dengue: NEAS Study Results

The global incidence of neurological complications of DENV varies between 5% and 21%. In Colombia, epidemic outbreaks of DENV…

How Insurance Affects Recovery After Traumatic Brain Injury

Insurance is an important social determinant of health that can contribute to health inequities. Many patients with traumatic brain injury…

Neurocognitive and Depression Risk in Urban Peru

This study investigates the prevalence and risk factors of neurocognitive disorders (NCD) and depression among community-dwelling younger…

Grapheme-Color Synesthesia in Patients with Epilepsy

Synesthesia, a condition where stimulation of one sensory pathway involuntarily triggers another (e.g., seeing colors when reading…

Atypical Presentation of Neurosyphilis

Neurosyphilis can manifest in various ways, often complicating the clinical picture.1 This condition is frequently overlooked…

Burnout in Critical Care Nurses Drops with Team Therapist: ATS 2025

Critical care nurses may find relief from burnout when a professional therapist is embedded directly within their hospital teams, according to new findings shared at this year’s American Thoracic Society (ATS) International Conference in San Francisco.

Can Psoriatic Arthritis Go Drug-Free? Surprising New Data

In a breakthrough study that could reshape long-term treatment strategies for psoriatic arthritis (PsA), researchers have found that a small but significant proportion of patients can achieve and maintain remission without the continued use of disease-modifying antirheumatic drugs (DMARDs).